Asthma and COPD in Alpha-1 Antitrypsin Deficiency. Evidence for the Dutch Hypothesis (Q37790365)

23 August 2017

title

Asthma and COPD in alpha-1 antitrypsin deficiency. Evidence for the Dutch hypothesis (English)

1 reference

23 August 2017

Asthma and COPD in Alpha-1 Antitrypsin Deficiency. Evidence for the Dutch Hypothesis (English)

1 reference

https://api.crossref.org/works/10.3109/15412555.2010.510159

chronic obstructive pulmonary disease

16 July 2024

main subject

asthma

0 references

1 reference

Edward Eden

1

1 reference

23 August 2017

language of work or name

English

0 references

publication date

1 October 2010

1 reference

full work available at URL

23 August 2017

http://www.tandfonline.com/doi/pdf/10.3109/15412555.2010.510159

1 reference

https://api.crossref.org/works/10.3109/15412555.2010.510159

COPD: Journal of Chronic Obstructive Pulmonary Disease

16 July 2024

published in

1 reference

23 August 2017

volume

7

1 reference

23 August 2017

issue

5

1 reference

23 August 2017

page(s)

366-374

1 reference

Clinical practice. Alpha1-antitrypsin deficiency

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

The Electrophoretic α;1-Globulin Pattern of Serum in α;1-Antitrypsin Deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

Emphysema with hereditary alpha-1 antitrypsin deficiency masquerading as asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

Asthma and allergy in alpha-1 antitrypsin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

Respiratory symptoms and lung function in young adults with severe alpha(1)-antitrypsin deficiency (PiZZ)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

Profile of bronchospastic disease in Puerto Rican patients in New York City. A possible relationship to alpha 1-antitrypsin variants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

Prevalence of alpha-1 antitrypsin deficiency in poorly controlled asthma--results from the ALA-ACRC low-dose theophylline trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

Alpha1 antitrypsin and the prevalence and severity of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

Alpha1-antitrypsin as a risk for infant and adult respiratory outcomes in a national birth cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

Delay in diagnosis of alpha1-antitrypsin deficiency: a continuing problem

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

Recombinant alpha 1-proteinase inhibitor blocks antigen- and mediator-induced airway responses in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

CD8+ T lymphocytes and leukotriene B4: novel interactions in the persistence and progression of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

Airway hyperresponsiveness in a large group of subjects with alpha1-antitrypsin deficiency: a cross-sectional controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

Genetic Susceptibility to Asthma — Bronchial Hyperresponsiveness Coinherited with a Major Gene for Atopy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

Skin test reactivity to common aeroallergens and decline of lung function. The Normative Aging Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

IL10 polymorphisms are associated with airflow obstruction in severe alpha1-antitrypsin deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

Development of predictive models for airflow obstruction in alpha-1-antitrypsin deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

Bronchodilator response in the lung health study over 11 yrs.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

Decline of lung function in adults with bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

Asthma as a risk factor for COPD in a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

Severe exacerbations and decline in lung function in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

Rate of progression of lung function impairment in alpha1-antitrypsin deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

Replacement therapy for hereditary alpha1-antitrypsin deficiency. A program for long-term administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

Exacerbations in subjects with alpha-1 antitrypsin deficiency receiving augmentation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

Inhaled corticosteroids and decline of lung function in community residents with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

S and Z alpha1-antitrypsin alleles are risk factors for bronchial hyperresponsiveness in young farmers: an example of gene/environment interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

Early intervention with inhaled corticosteroids in subjects with rapid decline in lung function and signs of bronchial hyperresponsiveness: Results from the DIMCA programme

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

Influence of deficient α1-anti-trypsin phenotypes on clinical characteristics and severity of asthma in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

A 15-Year Follow-up Study of Ventilatory Function in Adults with Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

Differences in Airway Inflammation in Patients with Fixed Airflow Obstruction Due to Asthma or Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2010.510159

[Bronchial asthma and homozygous alpha-1-antitrypsin deficiency (PiZZ) in 3 members of a family]

21 January 2018

7

1 reference

https://api.crossref.org/works/10.3109/15412555.2010.510159

Alpha 1 antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z. A survey by the British Thoracic Association

16 July 2024

8

1 reference

https://api.crossref.org/works/10.3109/15412555.2010.510159

The American Review of Respiratory Disease

16 July 2024

10

133

981

Dodge R.

1986

1 reference

https://api.crossref.org/works/10.3109/15412555.2010.510159

Asthma features in severe alpha1-antitrypsin deficiency: experience of the National Heart, Lung, and Blood Institute Registry

16 July 2024

11

1 reference

https://api.crossref.org/works/10.3109/15412555.2010.510159

Association of MS Pi phenotype with airway hyperresponsiveness

16 July 2024

16

1 reference

https://api.crossref.org/works/10.3109/15412555.2010.510159

Deficient alpha-1-antitrypsin phenotypes and persistent airflow limitation in severe asthma

16 July 2024

18

1 reference

https://api.crossref.org/works/10.3109/15412555.2010.510159

Low normal alpha-1-antitrypsin serum concentrations and MZ-phenotype are associated with byssinosis and familial allergy in cotton mill workers

16 July 2024

24

1 reference

https://api.crossref.org/works/10.3109/15412555.2010.510159

Prognosis in chronic obstructive pulmonary disease

16 July 2024

27

1 reference

https://api.crossref.org/works/10.3109/15412555.2010.510159

Effect of age and asthma duration upon elastase and α1-antitrypsin levels in adult asthmatics

16 July 2024

28

1 reference

https://api.crossref.org/works/10.3109/15412555.2010.510159

The interaction of alpha 1-proteinase inhibitor and tissue kallikrein in controlling allergic ovine airway hyperresponsiveness

16 July 2024

29

1 reference

https://api.crossref.org/works/10.3109/15412555.2010.510159

Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ)

16 July 2024

32

1 reference

https://api.crossref.org/works/10.3109/15412555.2010.510159

The effect of augmentation therapy on bronchial inflammation in alpha1-antitrypsin deficiency

16 July 2024

34

1 reference

https://api.crossref.org/works/10.3109/15412555.2010.510159

Alpha-1-protease inhibitor in bronchial asthma: phenotypes and biochemical characteristics

16 July 2024

35

1 reference

https://api.crossref.org/works/10.3109/15412555.2010.510159

The American Review of Respiratory Disease

16 July 2024

37

145

300

Tashkin DP

1992

1 reference

https://api.crossref.org/works/10.3109/15412555.2010.510159

Atopy, asthma, and emphysema in patients with severe alpha-1-antitrypysin deficiency

16 July 2024

41

1 reference

https://api.crossref.org/works/10.3109/15412555.2010.510159

Longitudinal changes in physiological, radiological, and health status measurements in alpha(1)-antitrypsin deficiency and factors associated with decline

16 July 2024

44

1 reference

https://api.crossref.org/works/10.3109/15412555.2010.510159

Asthma attacks with eosinophilia predict mortality from chronic obstructive pulmonary disease in a general population sample

16 July 2024

45

1 reference

https://api.crossref.org/works/10.3109/15412555.2010.510159

Long-term survival of a cohort of community residents with asthma

16 July 2024

47

1 reference

https://api.crossref.org/works/10.3109/15412555.2010.510159

Clinical characteristics of subjects with symptoms of alpha1-antitrypsin deficiency older than 60 years

16 July 2024

52

1 reference

https://api.crossref.org/works/10.3109/15412555.2010.510159

Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group

16 July 2024

53

1 reference

https://api.crossref.org/works/10.3109/15412555.2010.510159

16 July 2024

Identifiers

1 reference

23 August 2017

1 reference